Omega Diagnostics Group PLC
30 August 2007
30 August 2007
Omega Diagnostics Group plc
Results of Extraordinary General Meeting
Omega Diagnostics Group plc announces that at the Extraordinary General Meeting
of the company held today, all resolutions were duly passed.
Applications have been made to admit 14,875,693 New Ordinary Shares to trading
on AIM. It is expected that admission for 9,684,470 New Ordinary Shares becomes
effective on 31 August 2007 (the First Admission Shares) and that admission for
5,191,223 New Ordinary Shares becomes effective on 03 September 2007 (the Second
Admission Shares). Following the Second Admission the Company's issued share
capital will consist of 14,875,693 New Ordinary Shares with a nominal value of 4
pence each.
Following the capital reorganization and consolidation admission to AIM and
trading in the 123,245,615 Existing Ordinary Shares of 1 pence each will be
cancelled after 30 August 2007 and trading in the New Ordinary Shares of 4 pence
each will commence on 31 August 2007.
Contacts:
Omega Diagnostics Group PLC
Tel: 01259 763030
Andrew Shepherd, Chief Executive
Kieron Harbinson, Finance Director
www.omegadiagnostics.com
Landsbanki Securities (UK) Limited
Nominated Adviser & Broker
Tel: 020 7426 9000
Thilo Hoffmann/Simon Brown, Corporate Finance
Parkgreen Communications Limited
Ben Knowles
T. 020 7479 7933
Mob. 07900 346 978
Ben.knowles@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange